ROCKVILLE, Md.--(BUSINESS WIRE)--Neuralstem, Inc. (NYSEAmex:CUR) today responds to an earlier press release by StemCells, Inc. (STEM). On May 13, 2009, the United States Patent and Trademark Office (“PTO”) confirmed that two of STEM’s patents are invalid as the claims were originally granted. However, as we have come to expect, STEM has completely mischaracterized the outcome of the PTO reexamination proceeding concerning U.S. Patent Nos. 6,294,346 and 7,101,709.
